Home
>
National Drug Code (NDC)
>
Revatio
Revatio - 55154-2729-4 - (sildenafil citrate)
Drug Information of Revatio
| Product NDC: | 55154-2729 |
| Proprietary Name: | Revatio |
| Non Proprietary Name: | sildenafil citrate |
| Active Ingredient(s): | 20 mg/1 & nbsp; sildenafil citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Revatio
| Product NDC: | 55154-2729 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021845 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050603 |
Package Information of Revatio
| Package NDC: | 55154-2729-4 |
| Package Description: | 90 POUCH in 1 CARTON (55154-2729-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-2729-6) |
NDC Information of Revatio
| NDC Code | 55154-2729-4 |
| Proprietary Name | Revatio |
| Package Description | 90 POUCH in 1 CARTON (55154-2729-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-2729-6) |
| Product NDC | 55154-2729 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sildenafil citrate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20050603 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | SILDENAFIL CITRATE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
